BrainsWay (BrainsWay) EV-to-Revenue : 1.33 (As of May. 26, 2024)

View and export this data going back to 2012. Start your Free Trial

What is BrainsWay EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BrainsWay's enterprise value is $45.68 Mil. BrainsWay's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $34.26 Mil. Therefore, BrainsWay's EV-to-Revenue for today is 1.33.

The historical rank and industry rank for BrainsWay's EV-to-Revenue or its related term are showing as below:

BRSYF' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.71 Med: 3.96 Max: 69.51
Current: 1.34

During the past 11 years, the highest EV-to-Revenue of BrainsWay was 69.51. The lowest was -0.71. And the median was 3.96.

BRSYF's EV-to-Revenue is ranked better than
77.14% of 831 companies
in the Medical Devices & Instruments industry
Industry Median: 3.24 vs BRSYF: 1.34

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), BrainsWay's stock price is $2.47. BrainsWay's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $1.03. Therefore, BrainsWay's PS Ratio for today is 2.39.

BrainsWay EV-to-Revenue Historical Data

The historical data trend for BrainsWay's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrainsWay EV-to-Revenue Chart

BrainsWay Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

3.49

2.40

1.76

-0.55

1.85

BrainsWay Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															-0.58	-0.29	0.92	1.85	1.36

Competitive Comparison of BrainsWay's EV-to-Revenue

For the Medical Devices subindustry, BrainsWay's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BrainsWay's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BrainsWay's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BrainsWay's EV-to-Revenue falls into.

BrainsWay EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BrainsWay's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	45.682	/	34.255
	=	1.33

BrainsWay's current Enterprise Value is $45.68 Mil.
BrainsWay's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $34.26 Mil.

BrainsWay (OTCPK:BRSYF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BrainsWay's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	2.47	/	1.033
	=	2.39

BrainsWay's share price for today is $2.47.
BrainsWay's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.03.

BrainsWay EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BrainsWay's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BrainsWay (BrainsWay) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BrainsWay Ltd (OTCPK:BRSYF) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

BWAY:USA BWAY:Israel

Address

19 Hartum Street, 3rd Floor, Bynet Building, Har Hotzvim, Jerusalem, ISR, 9777518

Website

https://www.brainsway.com

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.